Who’s Going to EACR 2027

Jun 14–17, 2027 Bilbao, Spain ~2.4k attendees Website

104 universities, cancer centres and companies, with 66 invited speakers and 55 exhibitors, at the European Association for Cancer Research (EACR) 2027 Congress, a ~2,400-person, almost entirely academic meeting of cancer researchers. As of Oct 13, 2026.

Showing 1–14 of 104 organizations

Organization	EACR 2027 Attendance
Gustave Roussy Villejuif, France
gustaveroussy.fr Cancer centres & hospitals Cancer hospital and research centre in Villejuif, near Paris, affiliated with Paris-Saclay University.	Talk Tue Jun 15 9:20–10:55am Part of Joint EACR-ASEICA Symposium: Cancer initiation Title to be announced Cancer biology Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Epigenetics and RNA regulation in cancer Harnessing genetic and epitranscriptomic vulnerabilities in cancer: ADAR1 targeting as a new therapeutic opportunity Genomics · Therapy & resistance Talk Tue Jun 15 5:30–6:15pm Part of Keynote Lecture Title to be announced
Institute for Research in Biomedicine (IRB Barcelona) Barcelona, Spain
irbbarcelona.org Universities & institutes Biomedical research institute in Barcelona, Spain, with research programmes that include cancer science.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Paediatric cancers Mapping tumour heterogeneity to reveal novel treatment opportunities in childhood cancer Paediatric · Genomics Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Cancer evolution, somatic mutation, and early detection Cancer driver mutations in normal tissues and its relation to cancer risk Genomics · Prevention & detection
Spanish National Cancer Research Centre (CNIO) Madrid, Spain
cnio.es Universities & institutes Spain's public cancer research centre, with basic research, translational programmes and an experimental therapeutics programme.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer and extrinsic influences Timely Programs in the Tumor Microenvironment of Lung Cancers Immunology Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Title to be announced Cancer biology Talk Thu Jun 17 9:45–11am Part of EACR-ESMO bench to bedside Plenary Session: Precision targeting of RAS-driven cancers - New biology, new therapies A triple therapy to target pancreatic cancer Therapy & resistance
EPFL Lausanne, Switzerland
epfl.ch Universities & institutes Federal technology institute in Lausanne; its ISREC institute studies cancer biology.	Talk Tue Jun 15 9:20–10:55am Part of Symposium: AI and machine learning to turn genome information into therapy predictions Virtual Patient Labs: AI-Driven Simulation and Diagnostics for Precision Oncology AI Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Epigenetics and RNA regulation in cancer Title to be announced Genomics
ETH Zurich Zurich, Switzerland
ethz.ch Universities & institutes Federal institute of technology and research university in Zurich.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Title to be announced Models Plenary Thu Jun 17 11:20am–12:05pm Circulating Tumor Cell Clusters Cancer biology
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Cancer centres & hospitals NCI-designated comprehensive cancer centre in New York City for cancer care and research.	Talk Mon Jun 14 2:25–2:50pm Part of Joint EACR-EACS-Molecular Oncology Session: Latest advances in cancer immune-based therapies Title to be announced Immunology Plenary Mon Jun 14 3:50–6:15pm Part of EACR 2027 Congress - Opening Session Opening Keynote Lecture: Targeting Dormant Metastasis Cancer biology · Therapy & resistance
Research Institute of Molecular Pathology (IMP) Vienna, Austria
imp.ac.at Universities & institutes Basic biomedical research institute at the Vienna BioCenter in Austria, largely funded by Boehringer Ingelheim.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Decoding tumor dependencies through in-vivo CRISPR screens Models · Genomics Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer plasticity, metastasis, and therapy resistance Title to be announced Cancer biology · Therapy & resistance
Stanford University Stanford, CA
stanford.edu Universities & institutes Private research university in Stanford, California, with a school of medicine.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance Plenary Thu Jun 17 12:05–1pm Keynote Lecture & Closing Remarks
University of Cambridge Cambridge, UK
cam.ac.uk Universities & institutes Public research university in Cambridge, UK, with a clinical school and cancer and stem cell research institutes.	Talk Tue Jun 15 9:20–10:55am Part of Joint EACR-ASEICA Symposium: Cancer initiation Fate versus Free will; how does the environment shape early tumour survival? Cancer biology Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Cancer prevention and genomic instability / Epidemiology and molecular evidence to inform cancer prevention Decoding the earliest steps of BRCA-driven breast tumour initiation: towards rational prevention Prevention & detection
University of Turin Turin, Italy
unito.it Universities & institutes Public university in Turin, Italy.	Talk Wed Jun 16 3:20–4:55pm Part of Joint EACR-EMBO Symposium: Persister Cells Targeted therapy-induced genomic instability reveals synthetic lethal DDR vulnerabilities in colorectal cancer Therapy & resistance · Genomics Session Wed Jun 16 5:30–6:30pm Meet the Editors Panel
Vall d'Hebron Institute of Oncology (VHIO) Barcelona, Spain
vhio.net Cancer centres & hospitals Translational cancer research institute on the campus of Vall d'Hebron University Hospital in Barcelona, Spain.	Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Immunotherapy advances and predicting response Title to be announced Immunology Talk Wed Jun 16 3:20–4:55pm Part of Symposium: Revisiting MYC Bringing the first clinically viable MYC inhibitor to the bedside Therapy & resistance
Weizmann Institute of Science Rehovot, Israel
weizmann.ac.il Universities & institutes Multidisciplinary research institute and graduate school in Rehovot, Israel.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Systems immunology in cancer Title to be announced Immunology Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Tumor microenvironment Title to be announced Immunology
University College London (UCL) London, UK
ucl.ac.uk Universities & institutes Public research university in London, home to the UCL Cancer Institute.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Pharmacological activation of PI3Kα induces cancer cell death under metabolic stress Cancer biology · Therapy & resistance
Ludwig Institute for Cancer Research New York, NY
ludwigcancerresearch.org Universities & institutes International cancer research organisation running research branches and Ludwig Centers at universities in Europe and the United States.	Session Mon Jun 14 3:45–6:15pm EACR 2027 Congress - Opening Session Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance

Instantly find 20 buyers from organizations at EACR 2027

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is EACR 2027?

EACR 2027 runs June 14–17, 2027, at the Bilbao Exhibition Centre in Bilbao, Spain.

Where is the EACR 2027 program?

This guide lists every organization on the EACR 2027 program with its sessions; the full program is on the official website.

How do I register for EACR 2027?

Fees and registration are on the organizer's registration page.

What conference is this?

EACR 2027 is the European Association for Cancer Research’s annual congress, held June 14–17, 2027 at the Bilbao Exhibition Centre, with pre-congress sessions on June 13. About 2,400 cancer researchers attend, almost all from universities, research institutes and cancer centres, alongside an exhibition of research-tools companies.

What is in this guide?

Every organization we can place at EACR 2027 so far: the institutions of its 66 confirmed invited speakers (66 talks and chaired sessions on the published programme) and its 55 confirmed exhibitors with their stand numbers — 104 organizations in one list. Speakers appear as a count, never by name. Many talk titles are still to be announced, and the abstract-selected talks and posters will follow after the abstract deadline (March 2, 2027).

How are organizations typed?

Universities and research institutes, cancer centres and hospitals, research-tools companies, CROs and publishers, pharma and biotech, and societies, charities and agencies. The topic filters are judged from each talk’s title and its session, and for an exhibitor from what it sells.

How current is it?

Pulled from the congress programme, its confirmed-speaker list and the exhibitor list (updated 06 October 2026) on October 13, 2026, eight months before the congress. The programme and exhibition will grow; a refresh is planned when the abstract-selected talks are announced.

Browse EACR 2027 by

Organization type

Topic

Exhibit hall

Exhibitors 55

Everyone

All organizations A–Z 104

Organizations with their own page

68 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by the European Association for Cancer Research. Submit a correction